Anhui Jingke Biotechnology Co., Ltd. was established in December 2021 and located in Tongling Economic and Technological Development Zone, Anhui Province. Focusing on the integration of synthetic biology R&D and industrialization, the company devotes itself to the research, development and industrial production of core intermediates for antibiotics, antiviral products and food additives. It has an R&D center run by Hefei Jingke Biotechnology Co., Ltd., as well as two production bases: Xuancheng Jingke Biotechnology Co., Ltd. and Tongling Jingke Biotechnology Co., Ltd., which are separately responsible for the R&D and production of relevant technologies and products.

Its subsidiaries have obtained many qualifications and honors including National High-tech Enterprise, Anhui Specialized, Refined, Unique & Innovative SME, Industrial Enterprise above Designated Size, Anhui Provincial Enterprise R&D Center and the 6th Batch of Xuancheng Jingting Talents Team. The company has over 250 employees, among which the R&D team has more than 60 members including 5 PHD holders and 10 masters. Meanwhile, the quality team has 32 staff with 8 QA personnel. Focusing on patent layout and protection, the company owns 38 authorized patents, with a number of other patent applications pending.

Relying on dual technical platforms of biosynthesis and chemical synthesis to manufacture pharmaceutical intermediates, the company adopts high-throughput screening and modification system. Combined with QbD top-level design, continuous production and green chemical processes, the company implements R&D and production of related products.